Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.088 | 0.2 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |